GSK Poaches New Vaccines R&D Chief From Pfizer

Looking To Close Gap On mRNA Leaders

 
• By Andrew McConaghie
GSK vaccines
GSK's vaccines division earned £7bn ($9.31bn) last year, but is facing competition, not least from Pfizer/BioNTech and Moderna's mRNA breakthrough. • Source: Alamy

More from Business

More from Scrip